The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Ĭompeting interests: The University of Utah Department of Obstetrics and Gynecology Program in Family Planning receives research funding from Bayer, Bioceptive, Contramed, Merck, Medicines 360, and Teva Pharmaceutical Industries Ltd. Team members receive support from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and the Office of Research on Women’s Health of the National Institute of Health, LMG via IK12HD085816, JNS via Award Number K12HD085852 and DKT via K24HD087436. Please direct all data access inquiries to Josi Bitencourt in the University of Utah, IRB office ( This research is an Investigator Initiated Study supported in part by TEVA pharmaceuticals. These restrictions require interested researchers to demonstrate completion of appropriate research ethics training (i.e., CITI training or comparable) prior to receiving data access. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.ĭata Availability: There are ethical restrictions on sharing the de-identified data analyzed in this study imposed by the University to Utah, Institutional Review Board ethics committee.
Received: JAccepted: OctoPublished: November 7, 2018Ĭopyright: © 2018 Sanders et al. PLoS ONE 13(11):Įditor: Nelly Rwamba Mugo, Kenya Medical Research Institute, UNITED STATES
Citation: Sanders JN, Adkins DE, Kaur S, Storck K, Gawron LM, Turok DK (2018) Bleeding, cramping, and satisfaction among new copper IUD users: A prospective study.
0 kommentar(er)
